CDKN2A and neuroendocrine carcinoma: Moreover, our observations corroborate the notion that the tumor suppressor protein p16Ink4A plays a dichotomous role in the lung, being a high-risk feature in neuroendocrine tumors and a marker of good prognosis in non-neuroendocrine carcinomas.